Solardis Health Ventures is a healthcare venture capital group that collaborates with entrepreneurs to innovate in the healthcare sector.

Solardis Health Ventures

Venture capital group that invests in exceptional teams building breakthrough medical devices.

In Medtech and Healthtech venture capital, is bigger always better with respect to fund size and driving returns?

At #LSIUSA24, we’ll hear from a diverse group of seasoned investors and emerging fund managers who will analyze the challenging math and philosophy of venture fund size. These panelists will discuss the strategic considerations behind fund size decisions, the misconceptions, and the ways that optimal fund size can help drive alignment between allocators, investors, and companies.

We’ll hear perspectives from:

• Dennis McWilliams (Moderator), Partner at SANTÉ, is a serial life science entrepreneur and innovator dedicated to globally commercializing medical technologies.

• Nancy Hong, PhD, is a life science investor with experience investing in both biopharmaceutical and medical device opportunities, operating experience, and varied GP and LP investing roles.

• Amir Soltanianzadeh is Founder & Managing Partner of Solardis Health Ventures, an early-stage VC group that invests in teams building breakthrough medical devices. Prior to Solardis, he was the CEO & Co-Founder of Spine Align. He led the company to an acquisition to one of the largest public medical device companies in the orthopedic industry.

• Owen Willis is Founder and General Partner of Opal Ventures, a New York based Pre-Seed venture fund specializing in Healthtech. The fund supports companies that are committed to increasing access to care and places a strong emphasis on investing in founders that are building out of lived experience in Healthtech, Medtech, and medical devices.

We are still accepting registrations for LSI USA ‘24 on March 18-22 in Dana Point, California. Visit our website to learn more and secure your spot.

🌟 Exciting news! 🌟 Acorai is thrilled to announce the successful closing of our oversubscribed series seed equity round! 🎉💰 

Thanks to the incredible support from investors, we have secured over $4.5 million in funding to fuel our clinical studies and pave the way for regulatory approval. 🚀

This comes after Acorai was awarded €2.3 million non-dilutive grant and €10 million future equity financing from the European Innovation Council (EIC). These additional investments will undoubtedly propel us even further towards our goals. 🌍💪

Leading the charge in this round is Solardis Health Ventures, with the participation from KHP Ventures, CARMA FUND Management GmbH and other amazing investors such as CerraCap Ventures and Golden Angels Investors. We're also thrilled to have received significant follow-on investment from our existing investors across Sweden and the EU. 🤝

After breakthrough device designation by the US FDA in August 2023, we are on track for approval with our global clinical study, CAPTURE-HF. With this incredible milestone, we're on track to have our monitoring system ready for clinical use by 2024. 💙⏰

To learn more about this milestone and our journey, click the link below! 👇

🔗 https://lnkd.in/erf44jRb

Thank you for your unwavering support, and stay tuned for more updates as we continue to revolutionize the way we tackle heart failure! 👏🤩

#Acorai #HeartFailureResearch #Innovation #ClinicalStudies #FundingRound #BreakthroughDevice #CAPTUREHF

Thank you again to the amazing team at Blinkpad, led by Priti Dugar, for organizing the NEXUS investor event! This was truly one of the best Healthcare events this past week at JPM, and I’m honored to have been a sponsor via Solardis Health Ventures.

Special thank you to my dear investor colleague & friend Manish Bhandari, MD of Angel Physicians Fund for inviting me to this exceptionally curated forum between leading VCs and medtech entrepreneurs!

#jpm2024 #blinkpad #nexus #medtech #VC

Solardis Health Ventures, led by Managing Partner & Founder Amir Soltanianzadeh, will be attending the 42nd Annual JP Morgan Healthcare Conference! #JPM2024

Metric
Company Name	Solardis Health Ventures
Symbol
MSH ID	COM:SOLARDISVENTURES
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Healthcare Venture Capital
Country	US
Stage
Employee Count	1
Website	solardisventures.com
LinkedIn	solardis-health-ventures
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:SOLARDISVENTURES

Solardis Health Ventures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue